High-dose-rate intra-cavitary brachytherapy combined with external beam radiation therapy for under 40-year-old patients with invasive uterine cervical carcinoma: clinical outcomes in 118 Patients in a Japanese multi-institutional study, JASTRO.

Yamashita H, Niibe Y, Toita T, Kazumoto T, Nishimura T, Kodaira T, Eto H, Kinoshita R, Tsujino K, Onishi H, Takemoto M, Hayakawa K.

Jpn J Clin Oncol. 2013 May;43(5):547-52. doi: 10.1093/jjco/hyt029. Epub 2013 Mar 8. PMID: 23475536 [PubMed – indexed for MEDLINE]

Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines.

Miyamoto Y, Nakagawa S, Wada-Hiraike O, Seiki T, Tanikawa M, Hiraike H, Sone K, Nagasaka K, Oda K, Kawana K, Nakagawa K, Fujii T, Yano T, Kozuma S, Taketani Y.

Oncol Rep. 2013 Jan;29(1):51-7. doi: 10.3892/or.2012.2072. Epub 2012 Oct 5.

Guidelines for respiratory motion management in radiation therapy.

Matsuo Y, Onishi H, Nakagawa K, Nakamura M, Ariji T, Kumazaki Y, Shimbo M, Tohyama N, Nishio T, Okumura M, Shirato H, Hiraoka M; Japan Conformal External Beam Radiotherapy Group; Japan Society of Medical Physics; Japan Society of Medical Physics; Japanese Society of Radiological Technology.

J Radiat Res. 2013 May;54(3):561-8. doi: 10.1093/jrr/rrs122. Epub 2012 Dec 13. PMID: 23239175 [PubMed – indexed for MEDLINE]

High-dose-rate interstitial brachytherapy for gynecologic malignancies–dosimetric changes during treatment period.

Onoe T, Nose T, Yamashita H, Yoshioka M, Toshiyasu T, Kozuka T, Oguchi M, Nakagawa K.

J Radiat Res. 2013 Jul 1;54(4):663-70. doi: 10.1093/jrr/rrs130. Epub 2013 Jan 7. PMID: 23297319 [PubMed – in process]

Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-α, NF-κB, TGF-β, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1α] and clinical outcomes following curative chemoradiation therapy in 10 pati

Shibata-Kobayashi S, Yamashita H, Okuma K, Shiraishi K, Igaki H, Ohtomo K, Nakagawa K.

Oncol Lett. 2013 Mar;5(3):903-910. Epub 2013 Jan 11. PMID: 23426606 [PubMed]

Dose verification of volumetric modulated arc therapy (VMAT) by use of in-treatment linac parameters.

Haga A, Sakumi A, Okano Y, Itoh S, Saotome N, Kida S, Igaki H, Shiraishi K, Yamashita H, Ohtomo K, Nakagawa K.

Radiol Phys Technol. 2013 Jul;6(2):335-42. doi: 10.1007/s12194-013-0205-6. Epub 2013 Mar 12. PMID: 23479401 [PubMed – in process]

Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.

Takahashi W, Yamashita H, Kida S, Masutani Y, Sakumi A, Ohtomo K, Nakagawa K, Haga A.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):426-31. doi: 10.1016/j.ijrobp.2013.02.019. Epub 2013 Apr 5. PMID: 23562767 [PubMed – indexed for MEDLINE]

Stereotactic body radiotherapy for metastatic lung cancer as oligo-recurrence: an analysis of 42 cases.

Takahashi W, Yamashita H, Niibe Y, Shiraishi K, Hayakawa K, Nakagawa K.

Pulm Med. 2012;2012:454107. doi: 10.1155/2012/454107. Epub 2012 Oct 4. PMID: 23094150 [PubMed]

In-treatment 4D cone-beam CT with image-based respiratory phase recognition.

Kida S, Masutani Y, Yamashita H, Imae T, Matsuura T, Saotome N, Ohtomo K, Nakagawa K, Haga A.

Radiol Phys Technol. 2012 Feb 13; 25

Single-arc volumetric modulated arc therapy planning for left breast cancer and regional nodes.

Sakumi A, Shiraishi K, Onoe T, Yamamoto K, Haga A, Yoda K, Ohtomo K, Nakagawa K.

J Radiat Res (Tokyo). 2012 Feb 2;53(1):151-3. PMID: 22240941.